Literature DB >> 8230436

Escape from in vivo restriction of Moloney mink cell focus-inducing viruses driven by the Mo+PyF101 long terminal repeat (LTR) by LTR alterations.

B K Brightman1, C Farmer, H Fan.   

Abstract

Mo+PyF101 M-MuLV is a variant Moloney murine leukemia virus containing polyomavirus F101 enhancers inserted just downstream from the M-MuLV enhancers in the long terminal repeat (LTR). The protein coding sequences for this virus are identical to those of M-MuLV. Mo+PyF101 M-MuLV induces T-cell disease with a much lower incidence and longer latency than wild-type M-MuLV. We have previously shown that Mo+PyF101 M-MuLV is defective in preleukemic events induced by wild-type M-MuLV, including splenic hematopoietic hyperplasia, bone marrow depletion, and generation of recombinant mink cell focus-inducing viruses (MCFs). We also showed that an M-MCF virus driven by the Mo+PyF101 LTR is infectious in vitro but does not propagate in mice. However, in these experiments, when a pseudotypic mixture of Mo+PyF101 M-MuLV and Mo+PyF101 MCF was inoculated into newborn NIH Swiss mice, they died of T-cell leukemia at times almost equivalent to those induced by wild-type M-MuLV. Tumor DNAs from Mo+PyF101 M-MuLV-Mo+PyF101 MCF-inoculated mice were examined by Southern blot analysis. The predominant forms of Mo+PyF101 MCF proviruses in these tumors contained added sequences in the U3 region of the LTR. The U3 regions of representative tumor-derived variant Mo+PyF101 MCFs were cloned by polymerase chain reaction amplification, and sequencing indicated that they had acquired an additional copy of the M-MuLV 75-bp tandem repeat in the enhancer region. NIH 3T3 cell lines infected with altered viruses were obtained from representative Mo+PyF101 M-MuLV-Mo+PyF101 MCF-induced tumors, and mice were inoculated with the recovered viruses. Leukemogenicity was approximately equivalent to that in the original Mo+PyF101 M-MuLV-Mo+PyF101 MCF viral stock. Southern blot analysis on the resulting tumors now predominantly revealed loss of the polyomavirus sequences. These results suggest that the suppressive effects of the PyF101 sequences on M-MuLV-induced disease and potentially on MCF propagation were overcome in two ways: by triplication of the M-MuLV direct repeats and by loss of the polyomavirus sequences.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8230436      PMCID: PMC238176     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Bone marrow depletion by 89Sr complements a preleukemic defect in a long terminal repeat variant of Moloney murine leukemia virus.

Authors:  Q X Li; H Fan
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Friend and Moloney murine leukemia viruses specifically recombine with different endogenous retroviral sequences to generate mink cell focus-forming viruses.

Authors:  L H Evans; M W Cloyd
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

3.  Nucleotide sequence of Moloney murine leukaemia virus.

Authors:  T M Shinnick; R A Lerner; J G Sutcliffe
Journal:  Nature       Date:  1981 Oct 15-21       Impact factor: 49.962

4.  Isolation of cDNA clones encoding T cell-specific membrane-associated proteins.

Authors:  S M Hedrick; D I Cohen; E A Nielsen; M M Davis
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

5.  Mutation near the polyoma DNA replication origin permits productive infection of F9 embryonal carcinoma cells.

Authors:  F K Fujimura; P L Deininger; T Friedmann; E Linney
Journal:  Cell       Date:  1981-03       Impact factor: 41.582

6.  Non-function of a Moloney murine leukaemia virus regulatory sequence in F9 embryonal carcinoma cells.

Authors:  E Linney; B Davis; J Overhauser; E Chao; H Fan
Journal:  Nature       Date:  1984 Mar 29-Apr 4       Impact factor: 49.962

7.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

8.  Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region.

Authors:  H T Cuypers; G Selten; W Quint; M Zijlstra; E R Maandag; W Boelens; P van Wezenbeek; C Melief; A Berns
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

9.  Analysis of the env gene of a molecularly cloned and biologically active Moloney mink cell focus-forming proviral DNA.

Authors:  R A Bosselman; F van Straaten; C Van Beveren; I M Verma; M Vogt
Journal:  J Virol       Date:  1982-10       Impact factor: 5.103

10.  Lymphomagenicity of recombinant mink cell focus-inducing murine leukemia viruses.

Authors:  M W Cloyd; J W Hartley; W P Rowe
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

View more
  13 in total

1.  Appearance of mink cell focus-inducing recombinants during in vivo infection by moloney murine leukemia virus (M-MuLV) or the Mo+PyF101 M-MuLV enhancer variant: implications for sites of generation and roles in leukemogenesis.

Authors:  J K Lander; B Chesebro; H Fan
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Sequence-specific and/or stereospecific constraints of the U3 enhancer elements of MCF 247-W are important for pathogenicity.

Authors:  N L DiFronzo; C A Holland
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

3.  Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb.

Authors:  A L Zaiman; J Lenz
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  The feline leukemia virus long terminal repeat contains a potent genetic determinant of T-cell lymphomagenicity.

Authors:  J Pantginis; R M Beaty; L S Levy; J Lenz
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  Leukemia virus long terminal repeat activates NFkappaB pathway by a TLR3-dependent mechanism.

Authors:  Ana L Abujamra; Remco A Spanjaard; Idowu Akinsheye; Xiansi Zhao; Douglas V Faller; Sajal K Ghosh
Journal:  Virology       Date:  2005-11-14       Impact factor: 3.616

6.  Tandemization of a subregion of the enhancer sequences from SRS 19-6 murine leukemia virus associated with T-lymphoid but not other leukemias.

Authors:  S W Granger; L M Bundy; H Fan
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

7.  The helper virus envelope glycoprotein affects the disease specificity of a recombinant murine leukemia virus carrying a v-myc oncogene.

Authors:  S W Granger; H Fan
Journal:  Virus Genes       Date:  2001-06       Impact factor: 2.332

8.  B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer.

Authors:  J Lovmand; A B Sorensen; J Schmidt; M Ostergaard; A Luz; F S Pedersen
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Suppressor mutations within the core binding factor (CBF/AML1) binding site of a T-cell lymphomagenic retrovirus.

Authors:  M J Martiney; L S Levy; J Lenz
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

10.  An array of murine leukemia virus-related elements is transmitted and expressed in a primate recipient of retroviral gene transfer.

Authors:  D F Purcell; C M Broscius; E F Vanin; C E Buckler; A W Nienhuis; M A Martin
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.